Stoop Thomas F, van Bodegraven Eduard A, Ten Haaft Britte H E A, van Etten-Jamaludin Faridi S, van Zundert Suzanne M C, Lambe Cécile, Tabbers Merit M, Gorter Ramon R
Amsterdam UMC, Location University of Amsterdam, Pediatric Surgical Center of Amsterdam, Emma Children's Hospital, Department of Pediatric Surgery, Amsterdam, The Netherlands.
Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, The Netherlands.
J Pediatr Gastroenterol Nutr. 2024 Feb;78(2):188-196. doi: 10.1002/jpn3.12043. Epub 2023 Dec 27.
OBJECTIVES/BACKGROUND: High-output stoma is one of the most common major morbidities in young children with an enterostomy that could lead to intestinal failure. Management of high-output enterostomy in children is mostly based on personal experience. This systematic review aims to clarify the evidence-based therapeutic approach of high-output enterostomy in children.
A systematic review was performed using Pubmed, Embase (Ovid), and Cochrane Library to identify studies published until March 20, 2023, following the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. The study population comprised children (i.e., age <18 years) with high-output enterostomy (i.e., jejuno-, ileo-, and/or colostomy), regardless of underlying aetiology. Interventions comprised any (non)pharmacological and/or surgical treatment. Interventions were compared with each other, placebos, and/or no interventions. Primary outcome was reduction of enterostomy output. Secondary outcomes were morbidity, mortality, quality of life, associated healthcare costs, and adverse events.
The literature search identified 4278 original articles of which 366 were screened on full text, revealing that none of the articles met the inclusion criteria.
This first systematic review on management of high-output enterostomy in children revealed that any evidence on the primary and secondary outcomes is lacking. There is an urgent need for evidence on conservative treatment strategies including fluid restrictions, dietary advices, oral rehydration solution, chyme re-infusion, and pharmacological and surgical treatments of high-output enterostomy in children, aiming to reduce the risk for short- and long-term complications. Till more evidence is available, a systematic and multidisciplinary step-up approach is needed. Therefore, a therapeutic work-up is proposed that could guide the care.
目的/背景:高输出量造口是小儿肠造口术后最常见的严重并发症之一,可导致肠衰竭。小儿高输出量肠造口的管理大多基于个人经验。本系统评价旨在阐明小儿高输出量肠造口的循证治疗方法。
按照2020年系统评价与Meta分析优先报告条目指南,使用PubMed、Embase(Ovid)和Cochrane图书馆进行系统评价,以识别截至2023年3月20日发表的研究。研究对象为患有高输出量肠造口(即空肠造口、回肠造口和/或结肠造口)的儿童(即年龄<18岁),无论其潜在病因如何。干预措施包括任何(非)药物和/或手术治疗。将干预措施相互比较,与安慰剂和/或无干预措施进行比较。主要结局是造口输出量减少。次要结局是发病率、死亡率、生活质量、相关医疗费用和不良事件。
文献检索共识别出4278篇原始文章,其中366篇进行了全文筛选,结果显示没有一篇文章符合纳入标准。
这项关于小儿高输出量肠造口管理的首次系统评价表明,缺乏关于主要和次要结局的任何证据。迫切需要关于保守治疗策略的证据,包括液体限制、饮食建议、口服补液溶液、食糜再输注以及小儿高输出量肠造口的药物和手术治疗,以降低短期和长期并发症的风险。在获得更多证据之前,需要一种系统的多学科逐步升级方法。因此,提出了一种可指导护理的治疗方案。